Publications

Export 7 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Phosphorylation  [Clear All Filters]
Journal Article
Poirier J, Miron J, Picard C, Gormley P, Théroux L, Breitner JCS, Dea D.  2014.  Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease.. Neurobiol Aging. 35 Suppl 2:S3-10.
Ehrich JM, Messinger DI, Knakal CR, Kuhar JR, Schattauer SS, Bruchas MR, Zweifel LS, Kieffer BL, Phillips PEM, Chavkin C.  2015.  Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.. J Neurosci. 35(37):12917-31.
Cao R, Gkogkas CG, de Zavalia N, Blum ID, Yanagiya A, Tsukumo Y, Xu H, Lee C, Storch K-F, Liu AC et al..  2015.  Light-regulated translational control of circadian behavior by eIF4E phosphorylation.. Nat Neurosci. 18(6):855-62.
De Schutter JW, Park J, Leung CYuen, Gormley P, Lin Y-S, Hu Z, Berghuis AM, Poirier J, Tsantrizos YS.  2014.  Multistage screening reveals chameleon ligands of the human farnesyl pyrophosphate synthase: implications to drug discovery for neurodegenerative diseases.. J Med Chem. 57(13):5764-76.
Naef L, Gjerde E, Long H, Richard D, C-D Walker.  2014.  Neonatal onset of leptin signalling in dopamine neurones of the ventral tegmental area in the rat.. J Neuroendocrinol. 26(12):835-43.
Mondragón-Rodríguez S, Perry G, Luna-Muñoz J, Acevedo-Aquino MC, Williams S.  2014.  Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.. Neuropathol Appl Neurobiol. 40(2):121-35.
Gangarossa G, Guzman M, Prado VF, Prado MAM, Daumas S, Mestikawy SEl, Valjent E.  2016.  Role of the atypical vesicular glutamate transporter VGLUT3 in l-DOPA-induced dyskinesia.. Neurobiol Dis. 87:69-79.